Shionogi Ownership
SGIOF Stock | USD 14.10 1.69 13.62% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Shionogi |
Shionogi Pink Sheet Ownership Analysis
About 53.0% of the company shares are owned by institutional investors. The book value of Shionogi was at this time reported as 3585.51. The company last dividend was issued on the 30th of March 2023. Shionogi Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Shionogi Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. Shionogi operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5693 people.The quote for Shionogi Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Shionogi Co contact Isao Teshirogi at 81 6 6202 2161 or learn more at https://www.shionogi.com.Currently Active Assets on Macroaxis
Other Information on Investing in Shionogi Pink Sheet
Shionogi financial ratios help investors to determine whether Shionogi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shionogi with respect to the benefits of owning Shionogi security.